MedDataX Logo

Volumetric Monitoring in Major Lung Surgery

NCT ID: NCT01455766

Last Updated: 2012-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-06-30

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis of this observational single-center clinical study was to explore the volumetric hemodynamic monitoring in the perioperative period in major and risky thoracic intervention. The investigators monitored the changes in the volumes of blood in the central vessels and heart chambers as well as a volume of fluid in pulmonary tissue (i. e. extravascular lung water).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this observational study is to investigate into changes in volumetric hemodynamic parameters obtained with a technique of transpulmonary indicator dilution after major thoracic intervention, including pneumonectomy and lobar resections. The important parameters of hemodynamics were monitored throughout the intervention and 48 hrs postoperatively, including extravascular lung water index, global end-diastolic volume index, etc.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonectomy Acute Pulmonary Edema

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

postpneumonectomy pulmonary edema extravascular lung water

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent
* Age above 18 and below 80
* Confirmed malignant bronchial neoplasm or
* Destructive pulmonary infection

Exclusion Criteria

* Pregnant
* Severe pulmonary hypertension
* Pulmonary tuberculosis
* Severe occlusive atherosclerosis of lower extremities
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Regional hospital of Arkhangelsk

UNKNOWN

Sponsor Role collaborator

University of Tromso

OTHER

Sponsor Role collaborator

Northern State Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vsevolod V. Kuzkov

Associate Professor, MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vsevolod V. Kuzkov, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Northern State Medical University

Mikhail M. Orlov, MD

Role: PRINCIPAL_INVESTIGATOR

Regional hospital of Arkhangelsk

Mikhail Y. Kirov, MD, PhD

Role: STUDY_CHAIR

Northern State Medical University

Lars J. Bjertnaes, MD, PhD

Role: STUDY_DIRECTOR

University of Trmsoe, Tromsoe, Norway

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Regional Hospital of Arkhangelsk

Arkhangelsk, Arkhangelskaya oblast, Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Russia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2005-2011

Identifier Type: -

Identifier Source: org_study_id